Manulife (Manufacturers Life Insurance)
BLCM

Manulife (Manufacturers Life Insurance)’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,045
Closed -$103K – 2975
2019
Q1 		$103K Buy
3,045
+115
+4% +$3.84K ﹤0.01% 2573
2018
Q4 		$85K Sell
2,930
-131
-4% -$5.81K ﹤0.01% 2456
2018
Q3 		$189K Sell
3,061
-219
-7% -$14.8K ﹤0.01% 2782
2018
Q2 		$242K Buy
3,280
+1,014
+45% +$79K ﹤0.01% 2969
2018
Q1 		$148K Sell
2,266
-50
-2% -$3.78K ﹤0.01% 3247
2017
Q4 		$195K Buy
2,316
+37
+2% +$3.63K ﹤0.01% 3022
2017
Q3 		$263K Buy
2,279
+47
+2% +$4.95K ﹤0.01% 2759
2017
Q2 		$261K Buy
2,232
+468
+27% +$58.1K ﹤0.01% 2793
2017
Q1 		$218K Buy
1,764
+196
+13% +$25.7K ﹤0.01% 2772
2016
Q4 		$214K Buy
1,568
+135
+9% +$24K ﹤0.01% 2731
2016
Q3 		$285K Buy
1,433
+189
+15% +$32.5K ﹤0.01% 2490
2016
Q2 		$161K Buy
1,244
+797
+178% +$88.7K ﹤0.01% 2892
2016
Q1 		$39K Sell
447
-44
-9% -$4.79K ﹤0.01% 3349
2015
Q4 		$99 Sell
491
-148
-23% -$26.5K ﹤0.01% 3098
2015
Q3 		$93 Hold
639
– – ﹤0.01% 3155
2015
Q2 		$136 Buy
+639
New +$157K ﹤0.01% 3177

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BLCM Position: Q2 2019 in Review

Manulife (Manufacturers Life Insurance) sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2019, closing a stake of 3,045 shares — an estimated $103K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BLCM in Q2 2015 and held it in 16 quarters. The position peaked at $285K in Q3 2016. 79 funds tracked by Wall St. Rank hold BLCM as of Q2 2019.

  • Manulife (Manufacturers Life Insurance) reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,045 Bellicum Pharmaceuticals, Inc. shares in Q2 2019, an estimated $103K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Bellicum Pharmaceuticals, Inc. position peaked at $285K in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2019.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2019, filed 14 Aug 2019.